---
schema_version: "secwatch.filing_event.v1"
accession: "0001636422-24-000148"
form_type: "8-K"
ticker: "HCAT"
cik: "0001636422"
company_name: "Health Catalyst, Inc."
filed_at: "2024-11-06T23:59:59+00:00"
generated_at: "2026-05-30T04:36:14.682104+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Health Catalyst Q3 revenue $76.4M, Adj. EBITDA $7.3M; acquires Intraprise for $43M

## Summary
- Q3 2024 total revenue $76.4M, net loss $14.7M, Adjusted EBITDA $7.3M (above guidance midpoint of $6-8M).
- FY 2024 Adjusted EBITDA guidance raised to $25-27M (from $24-26M); revenue guidance unchanged at $305-311M.
- Acquired Intraprise Health for $43M (cash and ~2.2M shares at $8.18); expected close by end of 2024, immaterial near-term financial impact.
- Appointed Dr. Jill Hoggard Green to board effective Dec 1, 2024; she is former CEO of The Queens Health System, a client.

## SEC filing metadata
- accession: 0001636422-24-000148
- form_type: 8-K
- ticker: HCAT
- cik: 0001636422
- company_name: Health Catalyst, Inc.
- filed_at: 2024-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 3.02, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636422/000163642224000148/0001636422-24-000148-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636422/000163642224000148/hcat-20241102.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001636422-24-000148
- JSON: https://secwatch.observer/filing/0001636422-24-000148.json
- Plain text: https://secwatch.observer/filing/0001636422-24-000148.txt

## Key facts
- Executive change
  Jill Hoggard Green was appointed as Director at Health Catalyst, Inc..
  - Action: appointed
  - Role: Director
  source text: On November 2, 2024, the board of directors (the “Board”) of the Company, upon the recommendation of the Nominating and Corporate Governance Committee, appointed Dr. Jill Hoggard Green to the Board, effective December 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1636422/000163642224000148/0001636422-24-000148-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.